CF PHARMTECH (02652) invested 1.3544 million Hong Kong dollars to repurchase 67,500 shares on May 26th.
Changfeng Pharmaceutical (02652) announced that on May 26, 2026, the company spent 1.3544 million Hong Kong dollars to repurchase 67,500 shares, at a repurchase price of 18.90-20.38 Hong Kong dollars per share.
CF PHARMTECH (02652) announces that on May 26, 2026, the company will spend 1.3544 million Hong Kong dollars to repurchase 67,500 shares at a repurchase price of 18.90-20.38 Hong Kong dollars per share.
Related Articles
TRANSTHERA-B (02617) has reached clinical cooperation and drug supply agreement with Shanghai Allist Pharmaceuticals Co., Ltd.
NetEase Music (09899) spent 15 million Hong Kong dollars to buy back 12,600 shares on May 26th.
Guotai Haitong: High oil prices lead to higher prices in the off-season and lower quantities, but aviation demand continues to grow.
TRANSTHERA-B (02617) has reached clinical cooperation and drug supply agreement with Shanghai Allist Pharmaceuticals Co., Ltd.
NetEase Music (09899) spent 15 million Hong Kong dollars to buy back 12,600 shares on May 26th.
Guotai Haitong: High oil prices lead to higher prices in the off-season and lower quantities, but aviation demand continues to grow.
